NCT02266147View on ClinicalTrials.gov

Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
B-cell Lymphoma
Interventions
DRUG

SD-101

RADIATION

Radiation therapy

Trial Locations (5)

14642

University of Rochester Medical Center, Rochester

52242

University of Iowa Hospitals and Clinics, Iowa City

60611

Northwestern University, Chicago

63110

Washington University School of Medicine, St Louis

94305-5151

Stanford University School of Medicine, Stanford

Sponsors
All Listed Sponsors
lead

Dynavax Technologies Corporation

INDUSTRY